BIMERVAX

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Italy, Lithuania, Spain.

Active ingredients

The drug BIMERVAX contains one active pharmaceutical ingredient (API):

1
UNII E68GYP6X53 - SARS-COV2 501.V2 VARIANT
 
Read more about

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 BIMERVAX Emulsion for injection MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J07BN02 J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BN Covid-19 vaccines
Discover more medicines within J07BN02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 3039577
ES Centro de información online de medicamentos de la AEMPS 1221709001
IT Agenzia del Farmaco 050631011
LT Valstybinė vaistų kontrolės tarnyba 1096868

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈